ストックスクリーナーアプリを入手
28.15
0.81%
-0.23
アフターアワーズ：
28.15
前日終値:
$28.38
開ける：
$29.26
24時間の取引高:
626.97K
Relative Volume:
1.27
時価総額：
$1.36B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-6.82%
1か月 パフォーマンス:
+2.55%
6か月 パフォーマンス:
+134.97%
1年 パフォーマンス:
+31.91%
1日の値動き範囲:
$27.84
$30.09
1週間の範囲:
$27.84
$31.34
52週間の値動き範囲:
$5.485
$32.28
Oruka Therapeutics Inc Stock (ORKA) Company Profile
ORKA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ORKA
Oruka Therapeutics Inc
|
28.15 | 1.37B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-13 | 開始されました | Jefferies | Buy |
| 2025-10-27 | 開始されました | Guggenheim | Buy |
| 2025-10-13 | 開始されました | Barclays | Overweight |
| 2025-05-22 | 開始されました | BTIG Research | Buy |
| 2025-02-04 | 開始されました | Wolfe Research | Outperform |
| 2024-10-11 | 開始されました | Stifel | Buy |
| 2024-10-07 | 開始されました | H.C. Wainwright | Buy |
| 2024-09-17 | 開始されました | Leerink Partners | Outperform |
| 2024-09-16 | 開始されました | TD Cowen | Buy |
| 2024-09-13 | 開始されました | Jefferies | Buy |
| 2018-02-27 | 開始されました | Ascendiant Capital Markets | Buy |
| 2013-10-09 | 開始されました | Dawson James | Buy |
すべてを表示
Oruka Therapeutics Inc (ORKA) 最新ニュース
Is Oruka Therapeutics Inc. stock a dividend growth opportunityJuly 2025 PreEarnings & Weekly Chart Analysis and Trade Guides - Улправда
ORKA-001 Psoriasis Trial: Fresh Phase 2 Update and What It Means for Investors - TipRanks
Braidwell LP Cuts Stake in Oruka Therapeutics, Inc. $ORKA - MarketBeat
Oruka Therapeutics appoints Chris Martin to board of directors By Investing.com - Investing.com India
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Oruka Therapeutics appoints Chris Martin to board of directors - Investing.com
Oruka Therapeutics Appoints Christopher Martin to Board - TipRanks
Oruka Therapeutics Announces New Board Member and Board Transition - The Manila Times
Oruka Therapeutics appoints Christopher Martin to board - MSN
Oruka Therapeutics (NASDAQ:ORKA) Reaches New 12-Month HighShould You Buy? - MarketBeat
B Group Inc. Increases Position in Oruka Therapeutics, Inc. $ORKA - Defense World
Oruka Therapeutics (ORKA) Stock Analysis Report | Financials & Insights - Benzinga
Oruka Therapeutics, Inc. $ORKA Shares Purchased by Geode Capital Management LLC - Defense World
Oruka Therapeutics, Inc. $ORKA Shares Purchased by Affinity Asset Advisors LLC - Defense World
Oruka Therapeutics (NASDAQ:ORKA) Sets New 52-Week HighWhat's Next? - MarketBeat
Oruka Therapeutics stock hits 52-week high, reaching $31.01 By Investing.com - Investing.com Nigeria
Can Oruka Therapeutics Inc. stock deliver consistent earnings growthCEO Change & AI Based Buy and Sell Signals - Newser
Will Oruka Therapeutics Inc. stock sustain high P E ratios2025 Volatility Report & Safe Capital Growth Plans - Newser
Is Oruka Therapeutics Inc. (HQ1) stock dividend growth reliable2025 Risk Factors & Consistent Profit Trading Strategies - Newser
Oruka Therapeutics stock hits 52-week high, reaching $31.01 - Investing.com
Should I hold or sell Oruka Therapeutics Inc. stock in 2025Market Movement Recap & AI Based Buy and Sell Signals - Newser
Is Oruka Therapeutics Inc. (HQ1) stock undervalued at current priceJuly 2025 Snapshot & Community Verified Trade Alerts - Newser
Is Oruka Therapeutics Inc. (HQ1) stock a momentum leaderQuarterly Portfolio Review & Long-Term Safe Investment Plans - Newser
Will Oruka Therapeutics Inc. stock see insider buyingMarket Growth Review & Consistent Profit Trading Strategies - Newser
How Oruka Therapeutics Inc. (HQ1) stock performs during market turbulence2025 Dividend Review & Breakout Confirmation Trade Signals - Newser
What valuation ratios show for Oruka Therapeutics Inc. (HQ1) stock2025 Support & Resistance & Reliable Breakout Forecasts - Newser
Will Oruka Therapeutics Inc. (HQ1) stock hit analyst forecastsWeekly Profit Analysis & Breakout Confirmation Alerts - Newser
Franklin Resources Inc. Purchases 292,421 Shares of Oruka Therapeutics, Inc. $ORKA - MarketBeat
ORKA-001 Advances Toward Yearly Dosing - Dermatology Times
Oruka Therapeutics (NASDAQ:ORKA) Stock Price Down 6.9%Here's Why - MarketBeat
Jefferies Financial Group Inc. Has $729,000 Stake in Oruka Therapeutics, Inc. $ORKA - MarketBeat
How Investors Are Reacting To Oruka Therapeutics (ORKA) Once-Yearly Psoriasis Treatment Breakthrough - Sahm
What drives Oruka Therapeutics Inc stock priceSupport Zone Identification & Rapid Capital Growth - earlytimes.in
Oruka Therapeutics (NASDAQ:ORKA) Reaches New 1-Year HighHere's What Happened - MarketBeat
Its Stock Has Paid Off Big Time For Oruka Therapeutics Inc - Setenews
Oruka Therapeutics stock hits 52-week high at 30.29 USD By Investing.com - Investing.com Nigeria
Oruka Therapeutics stock hits 52-week high at 30.29 USD - Investing.com
Does Oruka Therapeutics Inc. stock trade at a discount to peersJuly 2025 Volume & Weekly Market Pulse Alerts - newser.com
Jefferies Sticks to Its Buy Rating for Oruka Therapeutics (ORKA) - The Globe and Mail
Can Oruka Therapeutics Inc. (HQ1) stock hit consensus price targetsWeekly Trade Review & Capital Protection Trading Alerts - newser.com
Will Oruka Therapeutics Inc. (HQ1) stock rise with strong economyRate Cut & High Accuracy Trade Signal Alerts - newser.com
Oruka Therapeutics Inc (ORKA) 財務データ
Oruka Therapeutics Inc (ORKA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.31%
0.33%
大文字化:
|
ボリューム (24 時間):